Sage Journals: Discover world-class research

Abstract

Purpose: This study examines the impact of Strength-Based Cognitive-Behavioral Therapy (SBCBT) on high-risk youth with substance misuse, anxiety, and depression, who often show limited responses to traditional interventions. Method: Ninety-one Chinese youth in Hong Kong were randomly assigned to either an SBCBT intervention group or a treatment-as-usual control group. Participants completed pre- and post-intervention questionnaires, with t-tests and repeated measures ANOVA employed to assess intervention effectiveness. Results: Compared with the control group, the SBCBT group showed positive changes in resilience (F = 7.24, p = .009), beliefs and attitudes towards drug misuse (F = 4.82, p = .031), and drug-avoiding self-efficacy (F = 10.83, p = .001), alongside reduced depressive (F = 14.16, p < .001) and anxiety symptoms (F = 7.61, p = .007) post-intervention. Discussion: SBCBT appears to promote significant changes in both mental health and drug-related outcomes among young people at high risk.

Keywords

drug misuse mental health disorder dual diagnosis cognitive-behavioral therapy randomized control trial Chinese youth

Get full access to this article

View all access options for this article.

References

Babowitch

J. D.

Antshel

K. M.

(2016). Adolescent treatment outcomes for comorbid depression and substance misuse: A systematic review and synthesis of the literature. Journal of Affective Disorders, 201, 25–33. https://doi.org/10.1016/j.jad.2016.04.018

Bahji

(2024). Navigating the complex intersection of substance use and psychiatric disorders: A comprehensive review. Journal of Clinical Medicine, 13(4), 999. https://doi.org/10.3390/jcm13040999

Baker

K. D.

Lubman

D. I.

Cosgrave

E. M.

Killackey

E. J.

Pan Yuen

Hides

Baksheev

G. N.

Buckby

J. A.

Yung

A. R.

(2007). Impact of co-occurring substance use on 6-month outcomes for young people seeking mental health treatment. Australian & New Zealand Journal of Psychiatry, 41(11), 896–902. https://doi.org/10.1080/00048670701634986

Beck

A. T.

Epstein

Brown

Steer

R. A.

(1988a). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893. https://doi.org/10.1037/0022-006X.56.6.893

Beck

A. T.

Steer

R. A.

(1990). Manual for the Beck Anxiety Inventory. The Psychological Corporation.

Beck

A. T.

Steer

R. A.

Carbin

M. G.

(1988b). Psychometric properties of the beck depression inventory: Twenty-five years of evaluation. Clinical Psychology Review, 8(1), 77–100. https://doi.org/10.1016/0272-7358(88)90050-5

Beck

A. T.

Ward

C. H.

Mendelson

Mock

Erbaugh

(1961). An inventory for measuring depression. Archives of General Psychiatry, 4(6), 561–571. https://doi.org/10.1001/archpsyc.1961.01710120031004

Byrne

B. M.

Stewart

S. M.

Lee

P. W. H.

(2004). Validating the Beck Depression Inventory-II for Hong Kong community adolescents. International Journal of Testing, 4(3), 199–216. https://doi.org/10.1207/s15327574ijt0403_1

Cohen

(2013). Statistical power analysis for the behavioral sciences. Routledge.

10.

Connor

K. M.

Davidson

J. R. T.

(2003). Development of a new resilience scale: The Connor-Davidson resilience scale (CD-RISC). Depression and Anxiety, 18(2), 76–82. https://doi.org/10.1002/da.10113

11.

Driessen

Meier

Hill

Wetterling

Lange

Junghanns

(2001). The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol and Alcoholism, 36(3), 249–255. https://doi.org/10.1093/alcalc/36.3.249

12.

Fok

M. S.

Tsang

W. Y.

(2005). Development of an instrument measuring Chinese adolescent beliefs and attitudes towards substance abuse. Journal of Clinical Nursing, 14(8), 986–994. https://doi.org/10.1111/j.1365-2702.2005.01202.x

13.

Gold

S. M.

Enck

Hasselmann

Friede

Hegerl

Mohr

D. C.

Otte

(2017). Control conditions for randomised trials of behavioural interventions in psychiatry: A decision framework. The Lancet Psychiatry, 4(9), 725–732. https://doi.org/10.1016/S2215-0366(17)30153-0

14.

Halladay

Scherer

MacKillop

Woock

Petker

Linton

Munn

(2019). Brief interventions for cannabis use in emerging adults: A systematic review, meta-analysis, and evidence map. Drug and Alcohol Dependence, 204, 107565. https://doi.org/10.1016/j.drugalcdep.2019.107565

15.

Hides

Samet

Lubman

D. I.

(2010). Cognitive behaviour therapy (CBT) for the treatment of co-occurring depression and substance use: Current evidence and directions for future research. Drug and Alcohol Review, 29(5), 508–517. https://doi.org/10.1111/j.1465-3362.2010.00207.x

16.

Hong Kong Narcotics Division . (2020). Beat Drugs Fund Evaluation Question Sets . Retrieved January 20, 2025, from https://www.nd.gov.hk/en/beat_questions_2010R2.html

17.

Hong Kong Narcotics Division . (2023). Central Registry of Drug Abuse Seventy-Second Report . Retrieved January 20, 2025, from https://www.nd.gov.hk/en/crda_publications_and_statistics.html

18.

Jones-Smith

(2014). Strengths-based therapy: Connecting theory, practice and skills. Sage Publications.

19.

Jordan

C. J.

Andersen

S. L.

(2017). Sensitive periods of substance abuse: Early risk for the transition to dependence. Developmental Cognitive Neuroscience, 25, 29–44. https://doi.org/10.1016/j.dcn.2016.10.004

20.

Karlsson

Bergmark

(2015). Compared with what? An analysis of control-group types in cochrane and campbell reviews of psychosocial treatment efficacy with substance use disorders. Addiction, 110(3), 420–428. https://doi.org/10.1111/add.12799

21.

Kushner

M. G.

Abrams

Thuras

Hanson

K. L.

Brekke

Sletten

(2005). Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcoholism: Clinical and Experimental Research, 29(8), 1432–1443. https://doi.org/10.1097/01.alc.0000175072.17623.f8

22.

Leung

K. W.

(2001). A validation of the traditional Chinese (Hong Kong) versions of the Beck Anxiety Inventory (BAI) and the Beck Depression Inventory-II (BDI-II) [Doctoral dissertation, The University of Hong Kong]. HKU Theses Online (HKUTO) . https://hub.hku.hk/handle/10722/26381

23.

Cui

Guo

Liu

Luo

Zheng

Leckman

J. F.

(2022). Prevalence of mental disorders in school children and adolescents in China: Diagnostic data from detailed clinical assessments of 17,524 individuals. Journal of Child Psychology and Psychiatry, 63(1), 34–46. https://pubmed.ncbi.nlm.nih.gov/34019305/

24.

Lund

Docrat

Abdulmalik

Alem

Fekadu

Gureje

Gurung

Hailemariam

Hailemichael

Hanlon

(2019). Household economic costs associated with mental, neurological and substance use disorders: A cross-sectional survey in six low-and middle-income countries. BJPsych Open, 5(3), e34. https://doi.org/10.1192/bjo.2019.20

25.

Marshall

Reeson

Loverock

Lewis

A. E.

King

Ilyas

Dixon

C. C.

Viste

Azer

Chow

Safi

Kennedy

Abba-Aji

Greenshaw

A. J.

(2025). Evidence-based Interventions for youth with concurrent mental health and substance use disorders: A scoping review. Canadian Journal of Psychiatry, 70(5), 347–371. https://doi.org/10.1177/07067437241300957

26.

Martin

G. W.

Wilkinson

D. A.

Poulos

C. X.

(1995). The drug avoidance self-efficacy scale. Journal of Substance Abuse, 7(2), 151–163. https://doi.org/10.1016/0899-3289(95)90001-2

27.

Mojtabai

Olfson

Han

(2016). National trends in the prevalence and treatment of depression in adolescents and young adults. Pediatrics, 138(6), e20161878. https://doi.org/10.1542/peds.2016-1878

28.

Norman

G. R.

Sloan

J. A.

Wyrwich

K. W.

(2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592. https://doi.org/10.1097/01.MLR.0000062554.74615.4C

29.

Osman

Hoffman

Barrios

F. X.

Kopper

B. A.

Breitenstein

J. L.

Hahn

S. K.

(2002). Factor structure, reliability, and validity of the beck anxiety inventory in adolescent psychiatric inpatients. Journal of Clinical Psychology, 58(4), 443–456. https://doi.org/10.1002/jclp.1154

30.

Otasowie

(2021). Co-occurring mental disorder and substance use disorder in young people: Aetiology, assessment and treatment. BJPsych Advances, 27(4), 272–281. https://doi.org/10.1192/bja.2020.64

31.

Padesky

C. A.

Mooney

K. A.

(2012). Strengths-based cognitive-behavioural therapy: A four-step model to build resilience. Clinical Psychology & Psychotherapy, 19(4), 283–290. https://doi.org/10.1002/cpp.1795

32.

Peterson

Mikosz

C. A.

Luo

(2021). Assessment of annual cost of substance use disorder in US hospitals. JAMA Network Open, 4(3), e210242. https://doi.org/10.1001/jamanetworkopen.2021.0242

33.

Priester

M. A.

Browne

Iachini

Clone

DeHart

Seay

K. D.

(2016). Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: An integrative literature review. Journal of Substance Abuse Treatment, 61, 47–59. https://doi.org/10.1016/j.jsat.2015.09.006

34.

Prochaska

J. O.

DiClemente

C. C.

(1983). Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51(3), 390–395. https://doi.org/10.1037/0022-006X.51.3.390

35.

Seligman

M. E.

(2002). Authentic happiness: Using the new positive psychology to realize your potential for lasting fulfillment. Simon and Schuster.

36.

Stewart

S. H.

Conrod

P. J.

(2008). Anxiety disorder and substance use disorder co-morbidity: Common themes and future directions. In Stewart

S. H.

Conrod

P. J.

(Eds.), Anxiety and substance use disorders: The vicious cycle of comorbidity (pp. 239–257). Springer Science + Business Media. https://doi.org/10.1007/978-0-387-74290-8_13

37.

Tanner-Smith

E. E.

Wilson

S. J.

Lipsey

M. W.

(2013). The comparative effectiveness of outpatient treatment for adolescent substance abuse: A meta-analysis. Journal of Substance Abuse Treatment, 44(2), 145–158. https://pubmed.ncbi.nlm.nih.gov/22763198/

38.

Vöhringer

P. A.

Ghaemi

S. N.

(2011). Solving the antidepressant efficacy question: Effect sizes in major depressive disorder. Clinical Therapeutics, 33(12), B49–B61. https://doi.org/10.1016/j.clinthera.2011.11.019

39.

Weaver

Rutter

Madden

Ward

Stimson

Renton

(2001). Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: Prevalence and service needs in an inner London borough. Social Psychiatry and Psychiatric Epidemiology, 36(8), 399–406. https://doi.org/10.1007/s001270170030

40.

Wong

D. F. K.

Cheung

C. H.

Chan

M. H.

Lee

S. C.

Chan

K. S.

Pang

M. F.

Ling

(2022). Research report on risk assessment tool of mental health and drug abuse behaviors among youth [Unpublished report]. Institute of Cognitive Therapy, The University of Hong Kong; The Hong Kong Federation of Youth Groups.

41.

Wong

D. F. K.

Cheung

Y. C. H.

Oades

L. G.

S. S.

Y. P.

(2024). Strength-based cognitive-behavioural therapy and peer-to-peer support in the recovery process for people with schizophrenia: A randomised control trial. The International Journal of Social Psychiatry, 70(2), 364–377. https://doi.org/10.1177/00207640231212096

42.

Wong

D. F. K.

R. W. M.

Chan

V. Y. C.

(2019). A strength-based cognitive behaviour therapy approach to recovery: From trapped to liberated self. Routledge. https://doi.org/10.4324/9780429200328

43.

Wong

D. F. K.

Zhuang

X. Y.

T. K.

(2020). Effectiveness of a culturally-attuned integrated cognitive behavioural therapy for Chinese young people with drug abuse in Hong Kong. Children and Youth Services Review, 113, 104970. https://psycnet.apa.org/record/2020-33424-001

44.

World Health Organization (WHO) . (2023). Drugs fact sheets (psychoactive) . Retrieved February, 20, 2025 from https://www.who.int/health-topics/drugs-psychoactive#tab=tab_1

45.

Zhang

(2007). Factor analysis and psychometric evaluation of the connor-davidson resilience scale (CD-RISC) with Chinese people. Social Behavior and Personality: An International Journal, 35(1), 19–30. https://doi.org/10.2224/sbp.2007.35.1.19

Strength-Based Cognitive-Behavioral Therapy for Reducing Concurrent Drug Misuse and Anxiety and Depression: A Randomized Controlled Trial

Abstract

Keywords

Get full access to this article

References